USD 224.84
(-0.5%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 55.77 Million USD | -8.53% |
2023 | 60.97 Million USD | 11.7% |
2022 | 54.58 Million USD | -13.51% |
2021 | 63.11 Million USD | 15.12% |
2020 | 54.82 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q4 | 55.77 Million USD | -3.28% |
2024 Q3 | 57.66 Million USD | -1.43% |
2024 Q1 | 58.22 Million USD | -4.51% |
2024 FY | 55.77 Million USD | -8.53% |
2024 Q2 | 58.5 Million USD | 0.48% |
2023 Q2 | 63.47 Million USD | 17.39% |
2023 Q3 | 61.89 Million USD | -2.49% |
2023 FY | 60.97 Million USD | 11.7% |
2023 Q1 | 54.06 Million USD | -0.95% |
2023 Q4 | 60.97 Million USD | -1.48% |
2022 Q2 | 58.73 Million USD | -2.03% |
2022 Q1 | 59.95 Million USD | -5.02% |
2022 FY | 54.58 Million USD | -13.51% |
2022 Q4 | 54.58 Million USD | -2.59% |
2022 Q3 | 56.04 Million USD | -4.59% |
2021 Q1 | 52.55 Million USD | -4.14% |
2021 FY | 63.11 Million USD | 15.12% |
2021 Q4 | 63.11 Million USD | 6.95% |
2021 Q2 | 57.3 Million USD | 9.03% |
2021 Q3 | 59.01 Million USD | 2.98% |
2020 Q4 | 54.82 Million USD | 100.75% |
2020 Q1 | 19.27 Million USD | 0.0% |
2020 FY | 54.82 Million USD | 0.0% |
2020 Q2 | 22.24 Million USD | 15.45% |
2020 Q3 | 27.31 Million USD | 22.77% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Phreesia, Inc. | 11.98 Million USD | -365.451% |
Accuray Incorporated | 172.15 Million USD | 67.602% |
Align Technology, Inc. | 96.96 Million USD | 42.481% |
Elevance Health Inc. | 25.12 Billion USD | 99.778% |
AxoGen, Inc. | 69.29 Million USD | 19.507% |
Boston Scientific Corporation | 9.09 Billion USD | 99.387% |
CVS Health Corporation | 79.38 Billion USD | 99.93% |
Cardinal Health, Inc. | 5.6 Billion USD | 99.006% |
Centene Corporation | 17.69 Billion USD | 99.685% |
DaVita Inc. | 11.11 Billion USD | 99.498% |
HCA Healthcare, Inc. | 41.85 Billion USD | 99.867% |
Hologic, Inc. | 2.53 Billion USD | 97.799% |
Humana Inc. | 10.21 Billion USD | 99.454% |
IDEXX Laboratories, Inc. | 947.88 Million USD | 94.116% |
Laboratory Corporation of America Holdings | 5.95 Billion USD | 99.063% |
Masimo Corporation | 970 Million USD | 94.25% |
McKesson Corporation | 5.47 Billion USD | 98.981% |
Patterson Companies, Inc. | 762.94 Million USD | 92.689% |
Quest Diagnostics Incorporated | 5.36 Billion USD | 98.961% |
ResMed Inc. | 873.93 Million USD | 93.618% |
Henry Schein, Inc. | 2.74 Billion USD | 97.965% |
Teladoc Health, Inc. | 1.59 Billion USD | 96.497% |
Universal Health Services, Inc. | 5.36 Billion USD | 98.961% |
Baxter International Inc. | 14.36 Billion USD | 99.612% |
Becton, Dickinson and Company | 15.87 Billion USD | 99.649% |
Intuitive Surgical, Inc. | 89.8 Million USD | 37.89% |
Danaher Corporation | 19.35 Billion USD | 99.712% |
Stryker Corporation | 12.99 Billion USD | 99.571% |
Medtronic plc | 24.96 Billion USD | 99.777% |